Literature DB >> 21044070

Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.

Sung-Wook Jang1, Rajini Srinivasan, Erin A Jones, Guannan Sun, Sunduz Keles, Courtney Krueger, Li-Wei Chang, Rakesh Nagarajan, John Svaren.   

Abstract

Myelination of peripheral nerves by Schwann cells depends upon a gene regulatory network controlled by early growth response Egr2/Krox20, which is specifically required for Schwann cells to initiate and maintain myelination. To elucidate the mechanism by which Egr2 regulates gene expression during myelination, we have performed chromatin immunoprecipitation analysis on myelinating rat sciatic nerve in vivo. The resulting samples were applied to a tiled microarray consisting of a broad spectrum of genes that are activated or repressed in Egr2-deficient mice. The results show extensive binding within myelin-associated genes, as well as some genes that become repressed in myelinating Schwann cells. Many of the Egr2 peaks coincide with regions of open chromatin, which is a marker of enhancer regions. In addition, further analysis showed that there is substantial colocalization of Egr2 binding with Sox10, a transcription factor required for Schwann cell specification and other stages of Schwann cell development. Finally, we have found that Egr2 binds to promoters of several lipid biosynthetic genes, which is consistent with their dramatic up-regulation during the formation of lipid-rich myelin. Overall, this analysis provides a locus-wide profile of Egr2 binding patterns in major myelin-associated genes using myelinating peripheral nerve.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044070      PMCID: PMC3260055          DOI: 10.1111/j.1471-4159.2010.07045.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  74 in total

Review 1.  Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes.

Authors:  H Shimano
Journal:  Prog Lipid Res       Date:  2001-11       Impact factor: 16.195

2.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.

Authors:  L Kalaydjieva; D Gresham; R Gooding; L Heather; F Baas; R de Jonge; K Blechschmidt; D Angelicheva; D Chandler; P Worsley; A Rosenthal; R H King; P K Thomas
Journal:  Am J Hum Genet       Date:  2000-05-30       Impact factor: 11.025

3.  SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation.

Authors:  Kimberly M Taylor; Carole Labonne
Journal:  Dev Cell       Date:  2005-11       Impact factor: 12.270

4.  Gene profiling and bioinformatic analysis of Schwann cell embryonic development and myelination.

Authors:  Maurizio D'Antonio; David Michalovich; Morris Paterson; Anna Droggiti; Ashwin Woodhoo; Rhona Mirsky; Kristjan R Jessen
Journal:  Glia       Date:  2006-04-01       Impact factor: 7.452

5.  Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24.

Authors:  L Kalaydjieva; J Hallmayer; D Chandler; A Savov; A Nikolova; D Angelicheva; R H King; B Ishpekova; K Honeyman; F Calafell; A Shmarov; J Petrova; I Turnev; A Hristova; M Moskov; S Stancheva; I Petkova; A H Bittles; V Georgieva; L Middleton; P K Thomas
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

6.  A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease.

Authors:  E Bellone; E Di Maria; S Soriani; A Varese; L L Doria; F Ajmar; P Mandich
Journal:  Hum Mutat       Date:  1999-10       Impact factor: 4.878

7.  Different consequences of EGR2 mutants on the transactivation of human Cx32 promoter.

Authors:  Marco Musso; Piercesare Balestra; Franco Taroni; Emilia Bellone; Paola Mandich
Journal:  Neurobiol Dis       Date:  2003-02       Impact factor: 5.996

8.  Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements).

Authors:  Paul G Giresi; Jason D Lieb
Journal:  Methods       Date:  2009-03-18       Impact factor: 3.608

9.  In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.

Authors:  Sung-Wook Jang; Scott E LeBlanc; Avtar Roopra; Lawrence Wrabetz; John Svaren
Journal:  J Neurochem       Date:  2006-09       Impact factor: 5.372

10.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

View more
  22 in total

1.  Developmental regulation of microRNA expression in Schwann cells.

Authors:  Nolan G Gokey; Rajini Srinivasan; Camila Lopez-Anido; Courtney Krueger; John Svaren
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination.

Authors:  Holly Hung; Rebecca Kohnken; John Svaren
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

3.  Microprocessor complex subunit DiGeorge syndrome critical region gene 8 (Dgcr8) is required for schwann cell myelination and myelin maintenance.

Authors:  Hsin-Pin Lin; Idil Oksuz; Edward Hurley; Lawrence Wrabetz; Rajeshwar Awatramani
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

4.  Functional dissection of the Oct6 Schwann cell enhancer reveals an essential role for dimeric Sox10 binding.

Authors:  Noorjahan B Jagalur; Mehrnaz Ghazvini; Wim Mandemakers; Siska Driegen; Alex Maas; Erin A Jones; Martine Jaegle; Frank Grosveld; John Svaren; Dies Meijer
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

5.  Regulation of Peripheral Myelination through Transcriptional Buffering of Egr2 by an Antisense Long Non-coding RNA.

Authors:  Margot Martinez-Moreno; Timothy Mark O'Shea; John P Zepecki; Alexander Olaru; Jennifer K Ness; Robert Langer; Nikos Tapinos
Journal:  Cell Rep       Date:  2017-08-22       Impact factor: 9.423

6.  Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22.

Authors:  Erin A Jones; Megan H Brewer; Rajini Srinivasan; Courtney Krueger; Guannan Sun; Kira N Charney; Sunduz Keles; Anthony Antonellis; John Svaren
Journal:  Hum Mol Genet       Date:  2011-12-15       Impact factor: 6.150

7.  Regulation of the PMP22 gene through an intronic enhancer.

Authors:  Erin A Jones; Camila Lopez-Anido; Rajini Srinivasan; Courtney Krueger; Li-Wei Chang; Rakesh Nagarajan; John Svaren
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

8.  Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression.

Authors:  Nolan G Gokey; Camila Lopez-Anido; Anne Lynn Gillian-Daniel; John Svaren
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

9.  The roles of Egr-2 in autoimmune diseases.

Authors:  Min Zhang; Ying Wang; Jian-Shu Wang; Jiao Liu; Meng-Meng Liu; Hai-Bing Yang
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 10.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.